We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
36 hedge funds and large institutions have $41.6M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 40 → 36 (-4)
28% less capital invested
Capital invested by funds: $58.2M → $41.6M (-$16.6M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $199K
Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
16
Reduced
11
Closed
5
Calls
–
Puts
$199K
Net Calls
-$199K
Net Calls Change
+$158K
Top Buyers
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.43M |
| 2 |
RA
Royce & Associates
New York
|
+$372K |
| 3 |
AIP
ARS Investment Partners
New York
|
+$215K |
| 4 |
LPL Financial
San Diego,
California
|
+$104K |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$95.1K |
